8 MG AFLIBERCEPT:
A NEW DAWN IN TREATMENT OF RETINAL VASCULAR DISEASES
Livestream
12.6. 2024 at 17:30 - 19:30
Chairman:
Assoc. Prof. Jana Štefaničková, PhD., Bratislava, Slovakia
Dr. Balázs Varsányi, Pécs, Hungary
Topics:
Turning point in retinal vascular diseases
How to address current clinical challenges?
Pulsar trial – from theory to real life
Photon trial – from theory to real life
Product information:
Event partner:
Bayer, spol. s. r. o.
Twin City, Blok A, Karadžičova 2, 811 09 Bratislava, Slovakia.
recepcia.sk@bayer.com; tel: +421 2 592 13 321
The webinar is organized under the auspices of the Slovak Ophthalmological Society with the support of Bayer.
Participation in the event is included in the medical education system and participants will be awarded 2 credits.
Each webinar participant must be registered in advance.
